InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

ACRV stock results show that Acrivon Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

EVOK Stock Earnings: Evoke Pharma Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

EVOK stock results show that Evoke Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024

By InvestorPlace Earnings

ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024

By InvestorPlace Earnings

Candel Therapeutics just reported results for the second quarter of 2024.

Load More